Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06721234

Enrollment

100

Registered

2024-12-06

Start date

2024-12-02

Completion date

2025-07-30

Last updated

2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behçet

Brief summary

Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

19 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients fulfill the International Criteria for Behcet's Disease (ICBD) * Age above 18 years old * Patients cooperative and can answer questions * Patients who are able and willing to give informed consent

Exclusion criteria

* Other rheumatological and vascular diseases * Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests * Patients with hypertension , diabetes mellitus , malignant and active infectious diseases * Patients who are using aspirin and other platelet active drygs during the previous 6 months * patients who are not able and willing to give written consent

Design outcomes

Primary

Measure	Time frame
Femoral Vein Wall thickness	One week

Countries

Egypt

Contacts

Primary ContactEngy L Fawzy

engylouisfawzey@gmail.com01282665433

Outcome results